SEC Tracker
Get the app

Rocket Pharmaceuticals RCKT

Rocket Pharmaceuticals: completes an acquisition or sale of assets and makes a Regulation FD disclosure

Form
8-K
Filed
Importance
Routine
  • Completes an acquisition or sale of assets (2.01)
  • Makes a Regulation FD disclosure (7.01)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Rocket Pharmaceuticals files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Perspective Therapeutics CATX public float $213M, Jun 30, 2025
  2. Natures Sunshine Products NATR public float $211M, Jun 30, 2025
  3. Tvardi Therapeutics TVRD public float $207M, Jun 30, 2025
  4. Silence Therapeutics SLN public float $206M, Jun 30, 2025
  5. SELLAS Life Sciences Group SLS public float $219M, Jun 30, 2025